207_Combined course Presentations

5-FU = Cape in Pre-op Rectal Cancer: NSABP R-04

Capecitabine (825 mg BID) 50.4 Gy

+ Oxaliplatin

Stratify

(50 mg/m2 qw )

• T2 vs. T3 • M vs. F • SP vs. APR

R

CI 5-FU (225 mg/m2/d) 50.4 Gy

+ Oxaliplatin

n=1608

(50 mg/m2 qw)

NSABP R-04, Allegra et al; ASCO GI 2014